Antibody Portfolio
Get clear and easy to interpret results, with our antibody detection products including HLA screening, identification, single antigen, and Non-HLA antibody kits.
Explore Our Products
LIFECODES® LifeScreen XP and LIFECODES® LifeScreen Deluxe
Screen and monitor HLA Antibodies with confidence!
LIFECODES® Class I and Class II ID
Antibody identification and panel-reactive antibody (PRA) information are derived from native antigens.
LIFECODES® LSA-MIC Assay
Detect antibodies directed against MICA antigens with a comprehensive MICA single antigen panel.
LIFECODES® C3d Detection Assay
Detect C3d-binding donor specific anti-HLA antibodies (DSAs) for better risk stratification of patients.
LIFECODES® Non-HLA Antibody Assay
LIFECODES offers the complete antibody product portfolio for the transplant laboratory, including kits designed to detect and identify non-HLA antibodies in serum.
LIFECODES® Donor Specific Antibody Assay
Detect donor-specific HLA antibodies against Class I and/or Class II antigens.
LIFECODES® Single Antigen Assays (LSA)
The new, enhanced LSA Assays deliver increased coverage, optimized performance, and improve the overall workflow of the LIFECODES® HLA Antibody Analysis portfolio.
- Testimonial
- Transplant
- Customer
Overall, Nanopore sequencing is an excellent option for the future of HLA typing methodology.
Dr. Ana M Lazaro-Shiben, PhD, CHS, Immunogenetics Laboratory Johns Hopkins University School of Medicine
Let's Get Started On Your Story- Testimonial
- Transplant
- Customer
“We were astonished by the potential impact of this solution to enable sensitized patients to benefit from reliable epitopebased matching of deceased donors for the first time.”
Prof. Jean-Luc Taupin, PharmD, PhD, President of the Francophone Society of Histocompatibility and Immunogenetics, Immunology and Histocompatibility Laboratory, Saint-Louis Hospital
Let's Get Started On Your Story- Testimonial
- Transplant
- Customer
The technology is cost effective, scalable for the parallel typing of one-to-many samples, in a short period of time, providing excellent opportunities for the typing of deceased donors, elevating our matching capabilities to allow for epitope matching of these donors.
Prof. Dimitri S. Monos, PhD, Pathology and Laboratory Medicine, Perelman School of Medicine University of Pennsylvania
Let's Get Started On Your Story- Testimonial
- Transplant
- Customer
I really appreciate Immucor's continuous interest in listening to the customer. That is what makes Immucor a great partner to our labs. I know that our needs and ideas will be heard and taken into consideration to improve the products. That makes a world of difference to us in the labs and is truly appreciated.
Valia Bravo-Egana, PhD, F(ACHI), MBA, Director, Technical Supervisor and Clinical Consultant, Histocompatibility/Immunology Laboratory, Medical College of Georgia
Let's Get Started On Your Story- Testimonial
- Transplant
- Customer
Immucor products enable us to accurately assign HLA antibody specificities for better transplant outcomes!
Sam Ho, PhD, D(ABHI), FAACC, HLA Lab Director, Gift of Hope Organ & Tissue Donor Network
Let's Get Started On Your Story- Testimonial
- Transplant
- Customer
The fact that Immucor representatives are former transplant technologists adds one more layer of support for us. I appreciate Immucor's commitment to comprehensive customer support, from assay and software development to technical and educational support. It's a team approach between vendor and customer that is more than a business relationship. It's a joint mission to benefit patients.
Ellen Klohe, PhD, D(ABHI), HLA Laboratory Director, Vitalant Spokane Laboratory
Let's Get Started On Your StoryLabs We Serve
A leader in transfusion and transplantation diagnostics, Werfen is proud to partner with thousands of hospitals, clinical laboratories, reference laboratories and donor centers across the globe. Since 1982, we have been innovating on behalf of our customers, laboratories just like yours.
Select your lab type:
Upcoming Events,
Webinars & Workshops
Keep Up With Us
News & Blogs
Werfen acquires Omixon
Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for...
News & Blogs
PRESS RELEASE: Immucor and Pirche Announce Multi-Year Partnership
NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global...
News & Blogs
PRESS RELEASE: Immucor Announces New Innovations in Transplant Diagnostics
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion...
News & Blogs
MIA FORATM NGS EXPRESS HLA Typing Software: You Spoke, We Listened!
Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user...
News & Blogs
Coming Soon: Detect DP with LIFECODES® LifeScreen Deluxe!
Immucor is in the process of improving our LIFECODES® LifeScreen Deluxe (LMX) to add DP...
Experience Our Virtual Lab
Contact your sales representative for a personal tour.
